Evidence map›Paper›PMID 28395794›Full record

ArticleAcademic radiology2017

Performance Observations of Scanner Qualification of NCI-Designated Cancer Centers: Results From the Centers of Quantitative Imaging Excellence (CQIE) Program.

Mark Rosen, Paul E Kinahan, James F Gimpel, Adam Opanowski, Barry A Siegel, G Craig Hill, Linda Weiss, Lalitha Shankar

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Academic radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. NCTN Assessment on Current Applications of Radiomics in Oncology.International journal of radiation oncology, biology, physics · 2019
    Review
  5. Article
  6. Article
  7. Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Mark RosenDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania.
Paul E KinahanDepartment of Radiology, University of Washington, Seattle Washington.
James F GimpelCenter for Research and Innovation, American College of Radiology, Philadelphia, Pennsylvania. Electronic address: jgimpel@acr.org.
Adam OpanowskiCenter for Research and Innovation, American College of Radiology, Philadelphia, Pennsylvania.
Barry A SiegelMallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
G Craig HillCancer Imaging Program, Leidos Biomedical, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
Linda WeissOffice of Cancer Centers, National Cancer Institute, Bethesda, Maryland.
Lalitha ShankarCancer Imaging Program, National Cancer Institute, Bethesda, Maryland.
American College of Radiology · USNational Cancer Institute · USLeidos (United States) · USMallinckrodt (United States) · USUniversity of Pennsylvania · USUniversity of Washington · US

Funding

Project-006U10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · 2014 to 2026
$167.6M
Washington University/ Siteman Cancer Center Lead Academic SiteU10CA180833 · NCI · WASHINGTON UNIVERSITY · PI BARTLETT, NANCY L, KOZOWER, BENJAMIN D · 2014 to 2018
$7.6M
Advanced PET/CT Imaging for Improving Clinical TrialsU01CA148131 · NCI · UNIVERSITY OF WASHINGTON · PI KINAHAN, PAUL E., LINDEN, HANNAH M · 2010 to 2019
$6.0M
ECOG-ACRIN-Based QIN Resource for Advancing Quantitative Cancer Imaging in Clinical TrialsU01CA190254 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI SCHNALL, MITCHELL D. · 2015 to 2019
$3.2M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCI NIH HHS U01 CA148131NCI NIH HHS U01 CA190254NCI NIH HHS U10 CA180820NCI NIH HHS U10 CA180833
6 · The paper itself

Abstract

We present an overview of the Centers for Quantitative Imaging Excellence (CQIE) program, which was initiated in 2010 to establish a resource of clinical trial-ready sites within the National Cancer Institute (NCI)-designated Cancer Centers (NCI-CCs) network. The intent was to enable imaging centers in the NCI-CCs network capable of conducting treatment trials with advanced quantitative imaging end points. We describe the motivations for establishing the CQIE, the process used to initiate the network, the methods of site qualification for positron emission tomography, computed tomography, and magnetic resonance imaging, and the results of the evaluations over the subsequent 3 years.

Indexed as

Cancer Care FacilitiesClinical Trials as TopicEquipment DesignHumansMagnetic Resonance ImagingNational Cancer Institute (U.S.)NeoplasmsPhantoms, ImagingPositron-Emission TomographyTomography, X-Ray ComputedUnited Statescancer imagingclinical trialsimaging accreditationimaging credentialingphantom imagingScanner qualification

Identifiers

PMID28395794
PMCPMC5389125
OpenAlexW2557351942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.